These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3134513)

  • 1. A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy.
    Perez R; Lipton A; Harvey HA; Simmonds MA; Romano PJ; Imboden SL; Giudice G; Downing MR; Alton NK
    J Biol Response Mod; 1988 Jun; 7(3):309-17. PubMed ID: 3134513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic monitoring studies in advanced cancer patients treated with recombinant human gamma interferon (IFN-gamma 4A).
    Romano PJ; Lipton A; Harvey HA; Bartholomew MJ; Giudice G; Kloszewski F; Witkowski L; Downing MR
    Mol Biother; 1989; 1(4):208-12. PubMed ID: 2510768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II trial of human recombinant interferon gamma in renal cell carcinoma.
    Rinehart JJ; Malspeis L; Young D; Neidhart JA
    J Biol Response Mod; 1986 Aug; 5(4):300-8. PubMed ID: 3090208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
    Atkins MB; Robertson MJ; Gordon M; Lotze MT; DeCoste M; DuBois JS; Ritz J; Sandler AB; Edington HD; Garzone PD; Mier JW; Canning CM; Battiato L; Tahara H; Sherman ML
    Clin Cancer Res; 1997 Mar; 3(3):409-17. PubMed ID: 9815699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.
    Gollob JA; Mier JW; Veenstra K; McDermott DF; Clancy D; Clancy M; Atkins MB
    Clin Cancer Res; 2000 May; 6(5):1678-92. PubMed ID: 10815886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of combination therapy with interleukin 2 and beta-interferon in patients with advanced malignancy.
    Tamura T; Sasaki Y; Shinkai T; Eguchi K; Sakurai M; Fujiwara Y; Nakagawa K; Minato K; Bungo M; Saijo N
    Cancer Res; 1989 Feb; 49(3):730-5. PubMed ID: 2783385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.
    Sherwin SA; Foon KA; Abrams PG; Heyman MR; Ochs JJ; Watson T; Maluish A; Oldham RK
    J Biol Response Mod; 1984 Dec; 3(6):599-607. PubMed ID: 6439828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of recombinant human interferon gamma (S-6810) in renal cell carcinoma. Urological Cooperative Study Group of Recombinant Human Interferon Gamma (S-6810)].
    Machida T; Koiso K; Takaku F; Ogawa M
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):440-5. PubMed ID: 3101607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.
    Ohno R; Yamaguchi Y; Toge T; Kinouchi T; Kotake T; Shibata M; Kiyohara Y; Ikeda S; Fukui I; Gohchi A; Sugiyama Y; Saji S; Hazama S; Oka M; Ohnishi K; Ohhashi Y; Tsukagoshi S; Taguchi T
    Clin Cancer Res; 2000 Jul; 6(7):2661-9. PubMed ID: 10914707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
    Rinehart J; Malspeis L; Young D; Neidhart J
    Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design.
    Schiller JH; Pugh M; Kirkwood JM; Karp D; Larson M; Borden E
    Clin Cancer Res; 1996 Jan; 2(1):29-36. PubMed ID: 9816086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.
    Motzer RJ; Rakhit A; Schwartz LH; Olencki T; Malone TM; Sandstrom K; Nadeau R; Parmar H; Bukowski R
    Clin Cancer Res; 1998 May; 4(5):1183-91. PubMed ID: 9607576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion.
    Vadhan-Raj S; Nathan CF; Sherwin SA; Oettgen HF; Krown SE
    Cancer Treat Rep; 1986 May; 70(5):609-14. PubMed ID: 3085930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of recombinant methionyl human consensus interferon (r-metHuIFN-Con1).
    Neidhart JA; Schmidt S; Rosenblum M; Raber MN; Quesada JR; Alton NK; Downing M
    J Biol Response Mod; 1988 Jun; 7(3):240-8. PubMed ID: 3392552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I study of a recombinant gamma interferon (S-6810)].
    Ogawa M; Takaku F; Maekawa T; Ota K; Ichimaru M; Izuo M; Takakura K; Ikeda S; Koiso K; Machida T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):446-52. PubMed ID: 3101608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer.
    Portielje JE; Kruit WH; Schuler M; Beck J; Lamers CH; Stoter G; Huber C; de Boer-Dennert M; Rakhit A; Bolhuis RL; Aulitzky WE
    Clin Cancer Res; 1999 Dec; 5(12):3983-9. PubMed ID: 10632329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma.
    Gollob JA; Veenstra KG; Parker RA; Mier JW; McDermott DF; Clancy D; Tutin L; Koon H; Atkins MB
    J Clin Oncol; 2003 Jul; 21(13):2564-73. PubMed ID: 12829677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase I-II study of recombinant interferon gamma].
    Adachi K; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Nakada H; Tada A; Yamazaki H; Mukaiyama T
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1331-8. PubMed ID: 2988459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.